PLSE — PULSE BIOSCIENCES, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1625101 ·
Last close
$44.84
Market Cap
$3.30B
52W High
$58.94
52W Low
$12.56
ADV30
411,473
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 395,000 | 204,000 | -24,292,000 | -23,051,000 | 201,584,000 | 36,725,000 | 18,011,000 |
| Jun 2026 | 434,000 | 161,000 | -25,272,000 | -24,657,000 | 115,564,000 | 101,620,000 | 16,064,000 |
| Mar 2026 | 401,000 | 31,000 | -19,150,000 | -18,581,000 | 81,622,000 | 68,319,000 | 15,324,000 |
| Dec 2025 | 264,000 | 4,000 | -18,253,000 | -17,433,000 | 94,539,000 | 80,735,000 | 13,883,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-61,098,000
Investing CF
$-290,000
Financing CF
$56,659,000
CapEx
$-290,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.18
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-506,519,000
Inventory
$236,000
Receivables
$122,000
ST Investments
—
EBIT TTM
$-83,042,000
Pretax Income TTM
$-80,056,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,494,000
EBITDA
$-86,538,000
Free Cash Flow
$-46,423,376
Enterprise Value
$3,736,591,104
Total Cash
$189,194,000
Total Debt
$6,363,000
Shares Out
73,548,924
Trailing EPS
$-1.21
Book Value
$2.50
ROE
-60.6%
ROA
-35.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 350,000 | -76,939,000 | -72,781,000 | 94,539,000 | 13,883,000 | 80,656,000 | -54,122,000 |
| Dec 2024 | 0 | -56,257,000 | -53,585,000 | 132,460,000 | 17,598,000 | 114,862,000 | -36,343,000 |
| Dec 2023 | 0 | -43,574,000 | -42,210,000 | 59,154,000 | 14,794,000 | 44,360,000 | -33,041,000 |
| Dec 2022 | 700,000 | -58,057,000 | -58,505,000 | 77,877,000 | 80,125,000 | -2,248,000 | -47,013,000 |
TTM Snapshot
Revenues TTM
$1,185,000
NetIncome TTM
$-80,056,000
OpCashFlow TTM
—
Assets (Latest)
$115,564,000
Forward EPS
$-1.13
Max Pain — expiry 2027-01-15
max pain strike: $32.00 · spot: $45.83 · call oi: 1,545 · put oi: 60
Expected Move to 2027-01-15:
±$9.60
(20.95%) —
implied range
$36.23 –
$55.43
· ATM straddle on $45.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AXGN | Axogen, Inc. | $3.31B | $55.37 | — |
| TMDX | TransMedics Group, Inc. | $3.26B | $93.91 | — |
| IRTC | iRhythm Holdings, Inc. | $2.98B | $89.67 | — |
| NVST | Envista Holdings Corp | $3.80B | $23.70 | — |
| ATRC | AtriCure, Inc. | $2.80B | $55.02 | — |
News headlines (Yahoo Finance, 1h cache)
Pulse Biosciences (PLSE) Stock Looks Rich Following Early AF Study Enrollment
2026-11-19 00:23 · Yahoo
All You Need to Know About Pulse Biosciences (PLSE) Rating Upgrade to Buy
2026-11-18 16:00 · Yahoo
Pulse Biosciences Inc (PLSE) Q3 2026 Earnings Call Highlights: NanoPulse AF Study Enrollment ...
2026-11-06 19:13 · Yahoo
Pulse Bio (PLSE) Q3 2026 Earnings Call Transcript
2026-11-06 16:14 · Yahoo
What Pulse Biosciences (PLSE) Said on Its Q3 Earnings Call
2026-11-06 15:14 · Yahoo
Pulse Biosciences, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting
2026-11-06 12:00 · Yahoo
Pulse Biosciences, Inc (PLSE) Reports Q3 Loss, Misses Revenue Estimates
2026-11-06 00:00 · Yahoo
Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results
2026-11-05 21:05 · Yahoo
Pulse Biosciences to Present at Stifel 2026 Healthcare Conference
2026-10-29 17:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.